Fulcrum Therapeutics
Fulcrum Therapeutics develops small molecules that modulate gene expression to treat rare hematological disorders.
8-KSep 17Latest SEC filing, period to Sep 17
Aug 17Latest story
Sign inSign inFulcrum Therapeutics develops small molecules that modulate gene expression to treat rare hematological disorders.